Cipla USA, Inc. recalls Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio,…

Failed PH Specifications

Date

2026-01-28

Country

United States

Brand

Cipla

Product

Diclofenac Sodium Topical Gel, 1%, NET WT 100 g (3.53 oz), Manufactured by: DPT Laboratories, Ltd., 307 E Josephine Street, San Antonio,…

Classification

Class III

Units

Nationwide in the USA

Category

Drugs & medical

Source

FDA · Drug

Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer

What to do

1. Check the product name, strength and lot number against the official notice.
2. Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
3. Ask the pharmacy or supplier about a replacement or refund.

General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.

More Cipla recalls

1. 2026-04-22
2. US
   Drugs & medicalClass II

   Cipla USA, Inc. recalls Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manufactured by: Cipla Ltd., MIDC, Patalganga, India;…

   CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit

   FDA · DrugCipla USA, Inc.Nationwide in the USAOfficial notice →
3. 2026-04-15
4. US
   Drugs & medicalClass II

   Cipla USA, Inc. recalls Lanreotide Injection, 120 mg/0.5 mL, Box contains 1 Pre-filled syringe, Single dose only, Rx Only, Manufactured by: Pharmathen…

   Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for deficiencies in their visual inspection procedure.

   FDA · DrugCipla USA, Inc.Nationwide in the USAOfficial notice →
5. 2026-03-11
6. US
   Drugs & medicalClass III

   Cipla USA, Inc. recalls Nilotinib Capsules, 150 mg per capsule, packaged in cartons, Rx only, Manufactured by: Cipla Ltd., Verna, Goa, India, Manufactured for:…

   Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.

   FDA · DrugCipla USA, Inc.U.S.A. NationwideOfficial notice →
7. 2026-01-21
8. US
   Drugs & medicalClass II

   Cipla USA, Inc. recalls Lanreotide Injection, 120 mg/0.5 mL, 0.5 mL per pre-filled syringe, For deep subcutaneous injection, Rx Only, Manufactured for: Cipla USA,…

   Presence of Particulate Matter.

   FDA · DrugCipla USA, Inc.Nationwide in the USAOfficial notice →
9. 2025-12-17
10. US
    Drugs & medicalClass II

    Cipla USA, Inc. recalls Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard,…

    CGMP Deviations: the presence of a nitrosamine impurity, N-nitroso-cinacalcet, above the acceptable daily intake (ADI) limits.

    FDA · DrugCipla USA, Inc.Nationwide in the USOfficial notice →
11. US
    Drugs & medicalClass II

    Cipla USA, Inc. recalls Lanthanum Carbonate chewable tablets, 1000mg*, 10x9 bottles per patient pack carton, Rx Only, Manufactured by: Invagen Pharmaceuticals,…

    Failed stability specifications: Out of specification for hardness test

    FDA · DrugCipla USA, Inc.Nationwide in the USAOfficial notice →

Other drugs & medical recalls in the United States

1. 2026-01-28
2. US
   Drugs & medicalClass II

   Zydus Pharmaceuticals (USA) Inc recalls Icosapent Ethyl capsules, 1 gram, 120-count bottles, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India, Distributed…

   Subpotent Drug: Due to oxidation caused by leakage of the contents of the capsules

   FDA · DrugZydus Pharmaceuticals (USA) IncUS Nationwide.Official notice →
3. US
   Drugs & medicalClass II

   Specialty Process Labs LLC recalls Thyroid, USP, Rx only, Net Wt: 0.50kg, For Manufacturing, Processing or Repackaging Use Only, Specialty Process Labs, Phoenix, AZ…

   Subpotent Drug

   FDA · DrugSpecialty Process Labs LLCU.S. NationwideOfficial notice →
4. US
   Drugs & medicalClass II

   Graviti Pharmaceuticals Private Limited recalls Furosemide Tablets, USP 40 mg, 1,000 Tablets, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., East Brunswick, NJ…

   Presence of Foreign Substance

   FDA · DrugGraviti Pharmaceuticals Private LimitedU.S. NationwideOfficial notice →
5. 2026-01-22
6. US
   Drugs & medical

   Thrasio Recalls Angry Orange Enzyme Stain Removers Due to Risk of Exposure to Bacteria

   The recalled products can contain bacteria, including Pseudomonas aeruginosa, an environmental organism found widely in soil and water. People with weakened immune systems, external medical devices, or underlying lung…

   CPSCAbout 1,500,000 (In addition, about 43,700 were sold in…Official notice →
7. 2026-01-21
8. US
   Drugs & medicalClass II

   ICU Medical Inc. recalls Pulsator Arterial Blood Sampling Kit, Item Numbers 4044EG-1 4080P-2 4084P-1 4080PE 4080PG

   Affected lots of syringes may have a crack on the syringe collar, which may lead to delayed or repeated blood draw/fluid delivery. This issue may also lead to blood leakage during sampling of arterial blood or leakage…

   FDA · DeviceICU Medical Inc.US Nationwide distribution in the states of CA, FL, IL, IN, MA, MI, MN, MO,…Official notice →
9. US
   Drugs & medicalClass II

   Thoratec LLC recalls CentriMag Blood Pump, REF: 102953, 201-20003, 201-90010, 201-90016; CentriMag RVAD HDE KIT, REF: 104318; CentriMag Pre-connected Pack,…

   Acute circulatory support system pump may not fit into the motor and reports received of the pump not being securely locked into the motor using the screw-in locking feature. Failure to properly lock the pump into…

   FDA · DeviceThoratec LLCWorldwide - US Nationwide distribution including in the states of MN, PA, OK,…Official notice →